StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by billybob22on May 01, 2020 6:31pm

244 Views

Post# 30978190

RE:RE:RE:Cant beleive

Who the focks is Angela? I always get my info here at SH. Yesterday I went out on a limb and bought GILD sold at end of day. Down today again and this evening they are approved by the FDA, not thinkin about, not maybe, not in a year they are approved. Forget these little wannabe venture companies and thier pumpers.

I woundnt buy GILD now either....giving it away to save the planet. jmo

Bullboard Posts

Critical materials crisis: Diversifying away from China’s monopoly